Literature DB >> 32597813

Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Ernesto Solis1, Kevin N Hascup1,2,3, Erin R Hascup1,2.   

Abstract

While prevailing evidence supports that the amyloid cascade hypothesis is a key component of Alzheimer's disease (AD) pathology, many recent studies indicate that the vascular system is also a major contributor to disease progression. Vascular dysfunction and reduced cerebral blood flow (CBF) occur prior to the accumulation and aggregation of amyloid-β (Aβ) plaques and hyperphosphorylated tau tangles. Although research has predominantly focused on the cellular processes involved with Aβ-mediated neurodegeneration, effects of Aβ on CBF and neurovascular coupling are becoming more evident. This review will describe AD vascular disturbances as they relate to Aβ, including chronic cerebral hypoperfusion, hypertension, altered neurovascular coupling, and deterioration of the blood-brain barrier. In addition, we will describe recent findings about the relationship between these vascular defects and Aβ accumulation with emphasis on in vivo studies utilizing rodent AD models.

Entities:  

Keywords:  Amyloid-β peptide; amyloid cascade hypothesis; blood-brain barrier; cerebral amyloid angiopathy; chronic cerebral hypoperfusion; functional hyperemia; in vivo mouse model; in vivo rat model; neurovascular coupling; vascular hypothesis

Mesh:

Substances:

Year:  2020        PMID: 32597813      PMCID: PMC7483596          DOI: 10.3233/JAD-200473

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  231 in total

Review 1.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

Review 2.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 3.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

4.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Two types of sporadic cerebral amyloid angiopathy.

Authors:  Dietmar Rudolf Thal; Estifanos Ghebremedhin; Udo Rüb; Haruyasu Yamaguchi; Kelly Del Tredici; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging.

Authors:  Christian Luckhaus; Michael Oliver Flüß; Hans-Jörg Wittsack; Brigitte Grass-Kapanke; Michaela Jänner; Reza Khalili-Amiri; Wolfgang Friedrich; Tillmann Supprian; Wolfgang Gaebel; Ulrich Mödder; Mathias Cohnen
Journal:  Neuroimage       Date:  2007-12-14       Impact factor: 6.556

7.  White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion.

Authors:  Masunari Shibata; Ryo Ohtani; Masafumi Ihara; Hidekazu Tomimoto
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

8.  Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project.

Authors:  Chengxuan Qiu; Eva von Strauss; Bengt Winblad; Laura Fratiglioni
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

9.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging.

Authors:  Weiying Dai; Oscar L Lopez; Owen T Carmichael; James T Becker; Lewis H Kuller; H Michael Gach
Journal:  Radiology       Date:  2009-01-21       Impact factor: 11.105

10.  Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.

Authors:  Yun Zhai; Toru Yamashita; Yumiko Nakano; Zhuoran Sun; Jingwei Shang; Tian Feng; Ryuta Morihara; Yusuke Fukui; Yasuyuki Ohta; Nozomi Hishikawa; Koji Abe
Journal:  J Alzheimers Dis       Date:  2016-06-13       Impact factor: 4.472

View more
  21 in total

Review 1.  The Cognitive Effects of Radiotherapy for Brain Metastases.

Authors:  Eric J Lehrer; Brianna M Jones; Daniel R Dickstein; Sheryl Green; Isabelle M Germano; Joshua D Palmer; Nadia Laack; Paul D Brown; Vinai Gondi; Jeffrey S Wefel; Jason P Sheehan; Daniel M Trifiletti
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 2.  The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease.

Authors:  Yan-Li Zhang; Juan Wang; Zhi-Na Zhang; Qiang Su; Jun-Hong Guo
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

3.  The Protective Effects of Zeaxanthin on Amyloid-β Peptide 1-42-Induced Impairment of Learning and Memory Ability in Rats.

Authors:  Xiaoying Li; Ping Zhang; Hongrui Li; Huiyan Yu; Yuandi Xi
Journal:  Front Behav Neurosci       Date:  2022-06-23       Impact factor: 3.617

Review 4.  The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.

Authors:  Cui Yang; Qiu Yang; Yang Xiang; Xian-Rong Zeng; Jun Xiao; Wei-Dong Le
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

5.  Early disturbance of dynamic synchronization and neurovascular coupling in cognitively normal Parkinson's disease.

Authors:  Song'an Shang; Jing Ye; Jingtao Wu; Hongying Zhang; Weiqiang Dou; Vijaya Prakash Krishnan Muthaiah; Youyong Tian; Yingdong Zhang; Yu-Chen Chen; Xindao Yin
Journal:  J Cereb Blood Flow Metab       Date:  2022-04-26       Impact factor: 6.960

6.  Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD.

Authors:  Isadora Olivé; Nikos Makris; Maria Densmore; Margaret C McKinnon; Ruth A Lanius
Journal:  Hum Brain Mapp       Date:  2021-05-07       Impact factor: 5.399

7.  Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

Authors:  Victor Teatini Ribeiro; Thiago Macedo E Cordeiro; Roberta da Silva Filha; Lucas Giandoni Perez; Paulo Caramelli; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Ana Cristina Simões E Silva
Journal:  Front Neurosci       Date:  2021-04-06       Impact factor: 4.677

Review 8.  Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis.

Authors:  Cecilia Czakó; Tibor Kovács; Zoltan Ungvari; Anna Csiszar; Andriy Yabluchanskiy; Shannon Conley; Tamas Csipo; Agnes Lipecz; Hajnalka Horváth; Gábor László Sándor; Lilla István; Trevor Logan; Zoltán Zsolt Nagy; Illés Kovács
Journal:  Geroscience       Date:  2020-10-04       Impact factor: 7.713

Review 9.  SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Authors:  Mercedes Unzeta; Mar Hernàndez-Guillamon; Ping Sun; Montse Solé
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

10.  Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia.

Authors:  Christine A Olson; Alonso J Iñiguez; Grace E Yang; Ping Fang; Geoffrey N Pronovost; Kelly G Jameson; Tomiko K Rendon; Jorge Paramo; Jacob T Barlow; Rustem F Ismagilov; Elaine Y Hsiao
Journal:  Cell Host Microbe       Date:  2021-08-05       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.